Current disease status-First occurrence of the cancer Page 2 Posts on Medivizor
Navigation Menu

Current disease status-First occurrence of the cancer Posts on Medivizor

Can positron emission tomography predict the outcomes of patients with high risk rectal cancer?

Posted by on May 30, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the use of 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG-PET) to follow-up during treatment and predict the outcomes of patients with high-risk localized rectal cancer. Researchers suggested that this method can be very useful to assess the tumor before the surgery and predict response to...

Read More

Searching for patients with prostate cancer to test low-dose or high-dose brachytherapy

Posted by on May 28, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 3 trial is examining the effectiveness and safety of low dose rate (LDR) vs high dose rate (HDR) prostate brachytherapy (BT) for patients with prostate cancer (PC). The main outcome to be measured will be the quality of life in terms of urinary symptoms. This trial is recruiting in British Columbia,...

Read More

Further surgery or non-surgical options for patients with remaining breast cancer after surgery

Posted by on May 19, 2019 in Breast cancer | 0 comments

In a nutshell This study evaluated whether treating breast cancer that has not been completely removed with more surgery was more effective than non-surgical options such as chemotherapy. This study found that there was no difference in outcomes between treating with further surgery versus treating with a non-surgical option. Some...

Read More

Is vascular-targeted photodynamic therapy or active surveillance more effective in the treatment of low-risk prostate cancer?



Posted by on Apr 30, 2019 in Prostate cancer | 0 comments

In a nutshell This study examined if vascular-targeted photodynamic therapy (VTPT), or active surveillance is more effective in the treatment of low-risk prostate cancer. This study concluded that patients who received VTPT were less likely to require radical therapy compared to those who underwent active surveillance.  Some background...

Read More

Is leuprolide mesylate safe and effective in the treatment of advanced prostate cancer?



Posted by on Apr 24, 2019 in Prostate cancer | 0 comments

In a nutshell This study examined the safety and effectiveness of slow-release leuprolide mesylate (LM) administered by injection under the skin (leuprolide mesylate subcutaneous injectable suspension or LMIS), in the treatment of advanced prostate cancer. This study concluded that this medication is safe and effective in the treatment of advanced...

Read More

Long-short radiation therapy before surgery is associated with better outcomes in stage 2 and 3 rectal cancer

Posted by on Apr 21, 2019 in Colorectal cancer | 0 comments

In a nutshell This study compared the survival outcomes of patients with rectal cancer who underwent short- or long-course radiation therapy (RT). Researchers suggested that long-course RT was associated with greater tumor response and survival. Some background Colorectal cancer is the third most common cancer diagnosed in the United States. The...

Read More

How effective is radiotherapy for the treatment of advanced prostate cancer?

Posted by on Apr 13, 2019 in Prostate cancer | 0 comments

In a nutshell This study investigated the effectiveness of prostate radiotherapy (RT) in prostate cancer (PC). They found that prostate RT may improve survival in men with PC and fewer than 5 bone metastasis (cancer that has spread to the bones).  Some background Prostate cancer (PC) is a common and treatable cancer in men. One common type...

Read More